Gilead Sciences Inc (NASDAQ:GILD)

60.80
Delayed Data
As of Oct 23
 +0.13 / +0.21%
Today’s Change
59.65
Today|||52-Week Range
85.97
-6.43%
Year-to-Date
Where Things Stand in the Coronavirus Vaccine Race
10:15am / MotleyFool.com - Paid Partner Content
Why Gilead Sciences Stock Is on the Move Today
Oct 23 / MotleyFool.com - Paid Partner Content
2 Coronavirus Stocks to Avoid This Month
6:30am / MotleyFool.com - Paid Partner Content
Will Coronavirus Woes Affect Gilead's (GILD) Q3 Earnings?
Oct 23 / Zacks.com - Paid Partner Content
US Indexes Close Flat Friday
Oct 23 / GuruFocus News - Paid Partner Content
Gilead's Remdesivir First Drug to Win FDA Approval for Coronavirus
Oct 22 / MotleyFool.com - Paid Partner Content
Werner, Carlisle, Gilead, Intel and Mattel as Zacks Bull and Bear of the Day
Oct 23 / Zacks.com - Paid Partner Content
Stimulus or No? Plus News from GILD, Earnings from INTC & MAT
Oct 22 / Zacks.com - Paid Partner Content
Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus
Oct 23 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: BIIB Posts Q3 Results, VRTX Stops Study & Other Updates
Oct 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close60.67
Today’s open63.38
Day’s range60.50 - 63.63
Volume1,621,345
Average volume (3 months)9,047,386
Market cap$76.2B
Data as of 7:57pm ET, 10/23/2020

Growth & Valuation

Earnings growth (last year)+0.91%
Earnings growth (this year)+3.40%
Earnings growth (next 5 years)-0.70%
Revenue growth (last year)+0.49%
P/E ratioNM
Price/Sales3.72
Price/Book3.42

Competitors

 Today’s
change
Today’s
% change
ILMNIllumina Inc-2.44-0.75%
BIIBBiogen-1.73-0.65%
MRNAModerna Inc-0.32-0.45%
IMMUImmunomedics Inc0.000.00%
Data as of 5:58pm ET, 10/23/2020

Financials

Next reporting dateOctober 29, 2020
EPS forecast (this quarter)$1.90
Annual revenue (last year)$22.3B
Annual profit (last year)$5.4B
Net profit margin24.13%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Foster City, California

Forecasts